Research programme: orexinergic system modulators - Ferrer
Latest Information Update: 16 Jan 2016
At a glance
- Originator Ferrer
- Mechanism of Action Orexin receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Narcolepsy; Sleep disorders
Most Recent Events
- 16 Jan 2016 Early research in Sleep disorders in Spain (unspecified route)
- 16 Jan 2016 Early research in Narcolepsy in Spain (unspecified route)